PCSK9 inhibition in myeloid cells enhances cardioprotection beyond its LDL cholesterol-lowering effects
Preprint in medRxiv (August 2024)
The most recent citing publications are shown below. View all 78 publications that cite this research output on Dimensions.
Integrins and NAFLD-associated liver diseases: clinical associations, pathophysiological mechanisms and pharmacological implications
Article in Acta Biochimica et Biophysica Sinica (August 2024)
Inhibition of intrahepatic monocyte recruitment by Cenicriviroc and extracellular matrix degradation by MMP1 synergistically attenuate liver inflammation and fibrogenesis in vivo
Article in Scientific Reports (July 2024)